目的观察康莱特联合化疗治疗中晚期恶性肿瘤增敏减毒,提高生存质量的作用。方法68例病人,随机分成两组,冶疗组化疗同时加用康莱特100mqdiv连续一个月,对照组单纯化疗。结果治疗组中症状改善占48.57%,体重增加51.43%,KPS评分提高占48.60%,与对照组比较有显著差异(P<0.01)。结论康莱特与化疗联合应用有明显改善临床症状、提高生存质量的作用。 Objective To observe the role of Kanglaite combined chemotherapy in the treatment of advanced malignant tumors with attenuated sensitization and improved quality of life. Methods Sixty-eight patients were randomly divided into two groups. Chemotherapy combined with Kanglaite 100mqdiv for one month in the treatment group and chemotherapy alone in the control group. Results In the treatment group, the improvement of symptoms was 48.57%, the weight gain was 51.43%, the KPS score was increased by 48.60%, which was significantly different from the control group (P <0.01). Conclusions Kanglaite combined with chemotherapy can significantly improve the clinical symptoms and improve the quality of life.